Arnav Mehta

16PUBLICATIONS
134CO-AUTHORS
Molecular targetsPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 29, 2026
Discovery of Tcf7 regulators with clonally-resolved CRISPR screens identifies Trim28 as a mediator of CD8 T cell differentiation in tumors.

|Jun 24, 2026
Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance.

|Dec 11, 2025
Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer.

Alejandro Jiménez-Sánchez, Sitara Persad, Akimasa Hayashi

|Nov 18, 2025
Distinct Spatially Resolved Tumor Microenvironment Trajectories Define Benefit from Ramucirumab plus Pembrolizumab in Refractory PD-L1+ Gastric Cancer.

Sung Hee Lim, Minae An, You Jeong Heo

|Apr 08, 2025
The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and Application.

Anne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas

|Mar 18, 2025
Determinants of Response to Sequential Pembrolizumab with Trastuzumab plus Platinum/5-FU in HER2-Positive Gastric Cancer: A Phase II Chemoimmunotherapy Trial.

Sung Hee Lim, Minae An, Hyuk Lee

Pageof 3

Frequent Collaborators

6 joint publications

Nir Hacohen

4 joint publications

Hyuk Lee

4 joint publications

Seung Tae Kim

4 joint publications

You Jeong Heo